Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit

Mycoses

Volumn 49, Issue 6, 2006, Pages 484-492

  Ozturk, Mehmet Adnan ^a   Gunes, Tamer ^a   Koklu, Esad ^a   Cetin, Neside ^a   Koc, Nedret ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Candidiasis; Newborn; Oral nystatine; Prophylaxis

Indexed keywords

AMINOPHYLLINE; AMPHOTERICIN B; ANTIBIOTIC AGENT; FLUCONAZOLE; METHYLXANTHINE; NYSTATIN; STEROID; THEOPHYLLINE;

ARTICLE; CANDIDA; CANDIDIASIS; CONTROLLED STUDY; EXTREMELY LOW BIRTH WEIGHT; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NEWBORN; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZATION; STATISTICAL SIGNIFICANCE; THRUSH; TREATMENT OUTCOME; URINE CULTURE; VERY LOW BIRTH WEIGHT;

ADMINISTRATION, ORAL; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INTENSIVE CARE UNITS, NEONATAL; MALE; NYSTATIN; PHARYNX; RECTUM;

EID: 33749440414     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2006.01274.x     Document Type: Article

References (37)

1. Kicklighter DS, Springer SC, Cox T, Hubey TC, Turner RB. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics 2001; 107: 293-8.
2. Ng PC. Systemic fungal infections in neonates. Arch Dis Child 1994; 71: 130-5.
3. Peter D. Infection in the newborn. In: Rennie JM, Roberton NRC (eds), Textbook of Neonatology. Edinburg, Philadelphia, London, Toronto: Churchill Livingstone, 1999: 1109-202.
4. Friedman S, Richardson SE, Jacobs SE, O'brien K. Systemic Candida infection in extremely low birth weight infants: short term morbidity and long term neurodevelopmenttal outcome. Pediatr Infect Dis 2000; 19: 499-504.
5. Damjanovic V, Connolly MC, van Saene HKF et al. Selective decontamination with nystatin for control of a Candida outbreak in a Neonatal Intensive Care Unit. J Hosp Infect 1993; 24: 245-59.
6. Stoll BJ, Hansen N, Fanaroff AA et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110: 285-91.
7. Ronnestad A, Abrahamsen TG, Gaustad P, Finne PH. Blood culture isolated during 6 years in a tertiary Neonatal Intensive Care Unit. Scand J Infect Dis 1998; 30: 245-51.
8. Faix RG, Kovarik SM, Shaw TR, Johnson RV. Mucocutaneous and invasive candidiasis among very low birth weight (<1500 grams) infants in intensive care nurseries: a prospective study. Pediatrics 1989; 83: 101-7.
9. Stoll BJ, Gordon T, Korones SB, et al. Late-onset sepsis in very low birth weight neonates: a report from the National of Child Health and Human Development neonatal research network. J Pediatr 1996; 129: 63-71.
10. Lee BE, Cheung P, Robinson JL, Evanochko C, Robertson CM. Comparative study of mortality and morbidity in premature infants (birth weight <1250 g) with candidemia or candidal meningitis. Clin Infect Dis 1998; 27: 559-65.
11. Weese-Mayer DE, Fondriest DW, Brouillette RT, Shulman ST. Risk factors associated with candidemia in the Neonatal Intensive Care Unit: a case-control study. Pediatr Infect Dis J 1987; 6: 190-6.
12. Saiman L, Ludington E, Pfaller M et al. Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey Study Group. Pediatr Infect Dis J 2000; 19: 319-24.
13. Rowen JL, Rench MA, Kozinetz CA, Adams JM, Baker C. Endotracheal colonization with Candida enhances risk of systemic candidiasis in very low birth weight neonates. J Pediatr 1994; 124: 789-94.
14. Saxen H, Virtanen M, Carlson P et al. Neonatal Candida parapsilosis outbreak with a high case fatality rate. Pediatr Infect Dis J 1995; 14: 776-81.
15. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 2001; 345: 1660-6.
16. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Grossman LB. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight. J Pediatr 2005; 147: 172-9.
17. Bertini G, Perugi S, Dani C, Filippi L, Pratesi S, Rubaltelli FF. Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants. J Pediatr 2005; 147: 162-5.
18. Healy CM, Baker CJ, Zaccaria E, Campbell JR. Impact of fluconazoleprophylaxis on incidence and outcome of invasive candidiasis in a Neonatal Intensive Care Unit. J Pediatr 2005; 147: 166-71.
19. Manzoni P, Arisio R, Mostert M et al. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study 2. Pediatrics 2006; 117: 22-32.
20. Stone HH, Kolb LD, Currie CA, Geheber CE, Cuzzell JZ. Candida sepsis: pathogenesis and principles of treatment. Ann Surg 1974; 179: 697-711.
21. Stone HH, Geheber CE, Kolb LD, Kitchens WR. Alimentary tract colonization by Candida albicans. J Surg Res 1973; 14: 273-6.
22. van Saene HKF, Stoutenbeek CP, Faber-Nijholt R, van Saene JJM. Selective decontamination of the digestive tract contributes to the control of disseminated intravascular coagulation in severe liver impairment. J Pediatr Gastroenterol Nutr 1992; 14: 436-42.
23. Gauwerky J, Schmidt W, Kuhn H, Kubli F. Der vorzeitige Blasensprung: Falldarstellung einer schweren intrauterinen Pilzinfection. Geburtshilfe Frauenheilkd 1983; 43: 171-6.
24. Kellogg SG, Davis C, Benirschke K. Candida parapsilosis: previously unknown cause of fetal infection. A report of two cases. J Reprod Med 1974; 12: 159-62.
25. Weinstein RA, Stamm WE, Kramer L, Corey L. Pressure monitoring devices overlooked source of nosocomial infection. JAMA 1976; 236: 936-8.
26. Solomon SL, Alexander H, Eley JW et al. Nosocomial fungemia in neonates associated with intravascular pressure monitoring devices. Pediatr Infect Dis J 1986; 5: 680-5.
27. Phillips G, Golledge C. Fungal infection in neonates. J Antimicrob Chemother 1991; 28: 159-61.
28. Saiman L, Ludington E, Dawson JD et al. Risk factors for Candida species colonization of Neonatal Intensive Care Unit patients. Pediatr Infect Dis J 2001; 20: 1119-24.
29. Pappu-Katikaneni LD, Rao KP, Banister E. Gastrointestinal colonization with yeast species and Candida septicemia in very low birth weight infants. Mycoses 1990; 33: 20-3.
30. Alexander JW, Boyce ST, Babcock GF et al. The process of microbial translocation. Ann Surg 1990; 212: 496-512.
31. Sims ME, Yoo Y, You H, Salminen C, Walther FJ. Prophylactic oral nystatin and fungal infections in very-low-birthweight infants. Am J Perinatol 1988; 5: 33-6.
32. Burnie JP. Candida and hands. J Hosp Infect 1986; 8: 1-4.
33. Baley JE, Kliegman RM, Boxerbaum B, Fanaroff AA. Fungal colonization in the very low birth weight infant. Pediatrics 1986; 78: 225-32.
34. Huang Y, Li C, Lin T et al. Association of fungal colonization and invasive disease in very low birth weight infants. Pediatr Infect Dis J 1998; 17: 819-22.
35. El Masry FA, Neal TJ, Subhedar NV. Risk factors for invasive fungal infection in neonates. Acta Paediatr 2002; 91: 198-202.
36. Leibovitz E, Iuster-Reicher A, Amitai M, Mogilner B. Systemic candidal infections associated with use of peripheral venous catheters in neonates: a 9-year experience. Clin Infect Dis 1992; 14: 485-91.
37. Feja KN, Wu F, Roberts K et al. Risk factors for candidemia in critically ill infants: a matched case-control study. J Pediatr 2005; 147: 156-61.